Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Ultrasound contrast agent
Patent
1997-06-30
2000-04-04
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Ultrasound contrast agent
600458, 600441, A61K 4904, A61B 814
Patent
active
060457775
ABSTRACT:
It has been discovered microparticles formed from natural or synthetic polymer with thicker walls have significantly enhanced echogenicity as compared with microparticles having thinner walls. The effect of wall thickness has been determined experimentally as well as inserted into a formula for use in predicting the optimum conditions. In the preferred embodiment, the polymers are synthetic biodegradable polymers and the wall thickness is between about 100 and 660 nm, although wall thicknesses from about 20 nm to in excess of 500 nm can be used. The microparticles are manufactured with a diameter suitable for the targeted tissue to be imaged, for example, with a diameter of between 0.5 and 8 microns for intravascular administration, and a diameter of between 0.5 and 5 mm for oral administration for imaging of the gastrointestinal tract or other lumens. Preferred polymers are polyhydroxy acids such as polylactic acid-co-glycolic acid, polylactide or polyglycolide, most preferably conjugated to polyethylene glycol or other materials inhibiting uptake by the reticuloendothelial system (RES). The microspheres may be used in a variety of ultrasound imaging applications including cardiology applications, blood perfusion applications as well as for organ and peripheral vein imaging.
REFERENCES:
patent: 5123414 (1992-06-01), Unger
patent: 5334381 (1994-08-01), Unger
patent: 5352435 (1994-10-01), Unger
patent: 5611344 (1997-03-01), Bernstein et al.
patent: 5639473 (1997-06-01), Grinstaff et al.
Beck, L.R. et al., Fertil. Steril., 31, 545 (1979).
Benita, S. et al., J. Pharm. Sci., 73, 1721 (1984).
Carroll, B.A. et al., Invest. Radiol., vol. 15, pp. 260-266 (1980).
Carroll, B.A. et al., Radiology, vol. 143, pp. 747-750 (1982).
Church, C., J. Acoustical Soc. Amer., 97(3):1510-1521 (1995).
Commander, K.W. et al., J. Acoust. Soc. Amer., 85(2): 732-746 (1989).
Feinstein et al., J. Am. Coll. Cardiol., vol. 11, pp. 59-65 (1988).
Fritzsch, T. et al., Invest. Radiol, vol. 23 (Suppl 1), pp. 302-305 (1988).
Fritzsch, T. et al., Invest Radiol., vol. 25 (Suppl 1), 160-161 (1990).
Mathiowitz, E. et al., J. Scanning Microscopy, 4, 329 (1990).
Mathiowitz, E. et al., Reactive Polymers, 6, 275 (1987).
Ophir, J. and Parker, K.J., Contrast Agents in Diagnostic Ultrasound, Ultrasound in Medicine & Biology, vol. IS, n. 4, p. 319, 323 (1989).
Parker, K.J. and Wagg,R.C., "Measurement of Ultrasonic Attenuation Within Regions selected from B-Scan Images," IEEE Trans. Biomed. Enar. BME 30(8), pp. 431-437 (1983).
Parker, K.J., Wagg, R.C. and Lerner, R.M., "Attenuation of Ultrasound Magnitude and Frequency Dependence for Tissue Characterization," Radiology, 153(3), pp. 785-788 (1984).
Rovai, D. et al., J. Am. Coll. Cardiol., vol. 10, pp. 125-134 (1987).
Schneider et al., Invest. Radiol., vol. 27, pp. 134-139 (1992).
Smith, M. et al., J. Am. Coll. Cardiol., vol. 13, pp. 1622-1628 (1989).
Wible, J.H. et al., J. Am. Soc. Echocardiogr., vol. 9, pp. 442-451 (1996).
Bernstein Howard
Brush Henry T.
Church Charles C.
Straub Julie Ann
Acusphere, Inc.
Dees Jos,e G.
Hartley Michael G.
LandOfFree
Method for enhancing the echogenicity and decreasing the attenua does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for enhancing the echogenicity and decreasing the attenua, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for enhancing the echogenicity and decreasing the attenua will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-362085